| Thomas Schinecker |
Thomas Schinecker is currently the Chief Executive Officer at Roche Holding AG. He is also the Chief Executive Officer at Roche Diagnostics Belgium NV and the Chairman at Genentech, Inc. Additionally, he holds the position of Vice President at the International Federation of Pharmaceutical Manufacturers. In the past, he served as the Chief Executive Officer at Roche Pharmaceuticals, Inc. and Roche Diagnostics AG. He was also the Chief Executive Officer at Roche Diagnostics Scandinavia AB and held a position on the Member-Supervisory Board at Roche Diagnostics. GmbH. Furthermore, he was the Head of Marketing & Sales at Roche Diagnostics Graz GmbH. Dr. Schinecker obtained his doctorate degree from New York University in 2003. |
| Cristina A. Wilbur |
Cristina A. Wilbur is currently the Chief People Officer at Roche Holding AG. Prior to her current position, she served as the Chairman at International School of the Basel Region AG from 2017 to 2020. She also held the position of Director-Human Resources at Roche Diagnostics Corp. from 2002 to 2006 and at PerkinElmer Optoelectronics, Inc. in 2001. Additionally, she was the Head-Group Human Resources at Roche Group and the Manager-Human Resources & Payroll at EG&G, Inc. from 1992 to 1995. She also served as the Global Head-Human Resources & Senior VP at Roche Diagnostics (Switzerland) AG. Ms. Wilbur obtained her undergraduate degree from California Polytechnic State University (San Luis Obispo). |
| Levi A. Garraway |
Levi A. Garraway is the founder of Foundation Medicine, Inc. (founded in 2009) and Tango Therapeutics Sub, Inc. (founded in 2017). He is currently the Director, Chief Medical Officer & Executive VP at Genentech, Inc. since 2019 and the Chief Medical Officer & Head-Product Development at Roche Holding AG. Dr. Garraway's former positions include being the Director at the American Association for Cancer Research, Senior VP-Global Development & Medical Affairs at Eli Lilly & Co. from 2017 to 2019, and Assistant Professor at Dana-Farber Cancer Institute, Inc. from 2007 to 2011. |
| Severin Schwan |
Severin Schwan is currently the Chief Executive Officer & Director at F. Hoffmann-La Roche Ltd., the Chief Executive Officer at Roche Group, the Chairman at Roche Holding AG, the Chairman at Roche Holdings, Inc., the Chairman of Roche Pharma (Schweiz) AG, the Chairman-Supervisory Board of Roche Pharma AG, the Chairman-Supervisory Board of Roche Diagnostics Deutschland GmbH, the Chairman-Supervisory Board of Roche Diabetes Care GmbH, the Vice President of the International Federation of Pharmaceutical Manufacturers, a Member of the European Round Table of Industrialists, and a Member of the International Business Leaders Advisory Council. Formerly, Dr. Schwan was the Chief Executive Officer of Roche Diagnostics Corp. from 2006 to 2008. He also served as the Chairman of Genentech, Inc. and the Vice Chairman of Credit Suisse Group AG from 2014 to 2022. Additionally, he held positions such as Chairman-Member-Supervisory Board at Roche Diagnostics GmbH, Member of the Board of Directors at Credit Suisse AG, Director at Chugai Pharmaceutical Co., Ltd., Director at Credit Suisse (Schweiz) AG from 2015 to 2017, Head-Finance & Administration at Roche (Brussels) from 1995 to 1998, Head-Global Finance & Services at Roche Diagnostics AG from 2000 to 2004, Head-Finance & Informatics at Roche Deutschland Holding GmbH in 1998, and Head-Asia Pacific Region at Roche Diagnostics Asia Pacific Pte Ltd. from 2004 to 2006. Dr. Schwan obtained his undergraduate, graduate, and doctorate degrees from the University of Innsbruck in 1991 and 1993 respectively. |
| Alan Hippe |
Alan Hippe is currently serving as Vice Chairman at Roche Holdings, Inc. and Chairman-Supervisory Board at Roche Kapitalmarkt AG. He is also a Director at Genentech, Inc., Jacobs Holding AG, Colosseum Dental Group, Zahn Parent LLC, and Colosseum AG. Previously, he held positions such as Chief Financial & Information Officer at Roche Holding AG and Chief Financial Officer at Roche Group. Before his current roles, he served as Vice Chairman-Executive Board at FirstService Residential Florida, Inc., Chairman-Supervisory Board at ThyssenKrupp Risk & Insurance Services GmbH and Thyssenkrupp Reinsurance AG, and Director-Supervisory Board at Landesbank Hessen-Thüringen Girozentrale. He was also the Chief Financial Officer at Continental AG and CFO, Head-Controlling & Investor Relations at thyssenkrupp AG. Additionally, he served as a Member-Supervisory Board at Voith GmbH & Co. KGaA, Head-Controlling & IT Systems at AVECO Holding AG, and Senior VP-Controlling, Finance & Accounting at Fraport AG Stiftung ProRegion. He holds undergraduate and doctorate degrees from The Johannes Gutenberg University of Mainz. |
| Pascale Schmidt |
Pascale Schmidt has a current job as the Chief Compliance Officer at Roche Holding AG. |
